These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

787 related items for PubMed ID: 33185599

  • 1. The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease.
    Tai H, Hirano S, Sakurai T, Nakano Y, Ishikawa A, Kojima K, Li H, Shimada H, Kashiwado K, Mukai H, Horikoshi T, Sugiyama A, Uno T, Kuwabara S.
    J Alzheimers Dis; 2020; 78(4):1639-1652. PubMed ID: 33185599
    [Abstract] [Full Text] [Related]

  • 2. Relationships between cognitive impairment on ADAS-cog and regional cerebral blood flow using SPECT in late-onset Alzheimer's disease.
    Takahashi M, Oda Y, Okubo T, Shirayama Y.
    J Neural Transm (Vienna); 2017 Sep; 124(9):1109-1121. PubMed ID: 28509077
    [Abstract] [Full Text] [Related]

  • 3. Relationship of cognitive measures and gray and white matter in Alzheimer's disease.
    Baxter LC, Sparks DL, Johnson SC, Lenoski B, Lopez JE, Connor DJ, Sabbagh MN.
    J Alzheimers Dis; 2006 Aug; 9(3):253-60. PubMed ID: 16914835
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal Elderly adults at 3-tesla.
    Mak HK, Chan Q, Zhang Z, Petersen ET, Qiu D, Zhang L, Yau KK, Chu LW, Golay X.
    J Alzheimers Dis; 2012 Aug; 31(1):33-44. PubMed ID: 22504315
    [Abstract] [Full Text] [Related]

  • 6. Hippocampal perfusion in mild Alzheimer's disease.
    Rodriguez G, Vitali P, Calvini P, Bordoni C, Girtler N, Taddei G, Mariani G, Nobili F.
    Psychiatry Res; 2000 Dec 04; 100(2):65-74. PubMed ID: 11114492
    [Abstract] [Full Text] [Related]

  • 7. rCBF and cognitive impairment changes assessed by SPECT and ADAS-cog in late-onset Alzheimer's disease after 18 months of treatment with the cholinesterase inhibitors donepezil or galantamine.
    Shirayama Y, Takahashi M, Oda Y, Yoshino K, Sato K, Okubo T, Iyo M.
    Brain Imaging Behav; 2019 Feb 04; 13(1):75-86. PubMed ID: 29247294
    [Abstract] [Full Text] [Related]

  • 8. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease.
    Benedictus MR, Leeuwis AE, Binnewijzend MA, Kuijer JP, Scheltens P, Barkhof F, van der Flier WM, Prins ND.
    Eur Radiol; 2017 Mar 04; 27(3):1169-1175. PubMed ID: 27334014
    [Abstract] [Full Text] [Related]

  • 9. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F, Brugnolo A, Calvini P, Copello F, De Leo C, Girtler N, Morbelli S, Piccardo A, Vitali P, Rodriguez G.
    Clin Neurophysiol; 2005 Feb 04; 116(2):364-75. PubMed ID: 15661114
    [Abstract] [Full Text] [Related]

  • 10. A pilot study of brain morphometry following donepezil treatment in mild cognitive impairment: volume changes of cortical/subcortical regions and hippocampal subfields.
    Kim GW, Kim BC, Park KS, Jeong GW.
    Sci Rep; 2020 Jul 02; 10(1):10912. PubMed ID: 32616841
    [Abstract] [Full Text] [Related]

  • 11. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
    Nogueira J, Freitas S, Duro D, Almeida J, Santana I.
    Clin Neuropsychol; 2018 Jul 02; 32(sup1):46-59. PubMed ID: 29566598
    [Abstract] [Full Text] [Related]

  • 12. Correlation between both morphologic and functional changes and anxiety in Alzheimer's disease.
    Tagai K, Nagata T, Shinagawa S, Nemoto K, Inamura K, Tsuno N, Nakayama K.
    Dement Geriatr Cogn Disord; 2014 Jul 02; 38(3-4):153-60. PubMed ID: 24732302
    [Abstract] [Full Text] [Related]

  • 13. Neural Basis of Apathy in Patients with Amnestic Mild Cognitive Impairment.
    Kazui H, Takahashi R, Yamamoto Y, Yoshiyama K, Kanemoto H, Suzuki Y, Sato S, Azuma S, Suehiro T, Shimosegawa E, Ishii K, Tanaka T.
    J Alzheimers Dis; 2017 Jul 02; 55(4):1403-1416. PubMed ID: 27858707
    [Abstract] [Full Text] [Related]

  • 14. Poor performance in Clock-Drawing Test associated with visual memory deficit and reduced bilateral hippocampal and left temporoparietal regional blood flows in Alzheimer's disease patients.
    Takahashi M, Sato A, Nakajima K, Inoue A, Oishi S, Ishii T, Miyaoka H.
    Psychiatry Clin Neurosci; 2008 Apr 02; 62(2):167-73. PubMed ID: 18412838
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
    Beretta L, Caminiti SP, Santangelo R, Magnani G, Ferrari-Pellegrini F, Caffarra P, Perani D.
    Neuropsychologia; 2019 Oct 02; 133():107174. PubMed ID: 31446008
    [Abstract] [Full Text] [Related]

  • 19. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ, Gorno-Tempini ML, Schuff N.
    Radiology; 2005 Mar 02; 234(3):851-9. PubMed ID: 15734937
    [Abstract] [Full Text] [Related]

  • 20. An Arabic Version of the Cognitive Subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog): Reliability, Validity, and Normative Data.
    Ben Jemaa S, Attia Romdhane N, Bahri-Mrabet A, Jendli A, Le Gall D, Bellaj T.
    J Alzheimers Dis; 2017 Mar 02; 60(1):11-21. PubMed ID: 28505978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.